Encompass Health

EHC

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding

In their latest 13F (Q3 2026)

See who

Value held

$4.0m

Combined value at quarter end

Last quarter

0 bought

1 sold or trimmed

Price at Q2 ’26 end

$101.08

+4.5% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+12.6%Q3 ’24

-4.4%Q4 ’24

+9.7%Q1 ’25

+21.1%Q2 ’25

+3.6%Q3 ’25

-16.4%Q4 ’25

-8.9%Q1 ’26

+4.5%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

1Q4 ’23

1Q1 ’24

1Q2 ’24

1Q3 ’24

1Q4 ’24

1Q1 ’25

1Q2 ’25

1Q3 ’25

1Q4 ’25

1Q1 ’26

1Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes Encompass Health.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Encompass Health

Jensen Investment Management	0.1%$4.0m	$4.0m	Trimmed -22%	35 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works

From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.

Sort by

Insider purchases and sales of Encompass Health
		Bought or sold				Filing
31 Aug 2026	Price Andrew LChief Accounting Officer	▼ Sold	5,211	$120.93	$630k	Form 4
31 Aug 2026	Darby John PatrickEVP, Gen Counsel & Secretary	▼ Sold	4,858	$121.09	$588k	Form 4
10 Aug 2026	Tarr Mark JPresident & CEO	▼ Sold	171,569	$125.46	$21.5m	Form 4
10 Aug 2026	Coltharp Douglas EEVP & Chief Financial Officer	▼ Sold	18,869	$125.38	$2.4m	Form 4
10 Aug 2026	Darby John PatrickEVP, Gen Counsel & Secretary	▼ Sold	8,906	$125.95	$1.1m	Form 4
10 Aug 2026	Tarr Mark JPresident & CEO	▼ Sold	1,579	$126.06	$199k	Form 4

About the company

Sector: Health care · Services-Hospitals
Incorporated in: Delaware
Financial year ends: 31 December
Shares outstanding: 99m at 28 Jul 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

2013

2015

$3.9bn2017

$4.6bn2019

$4.0bn2021

$4.8bn2023

$5.9bn2025

Encompass Health revenue and net income by year
Year	Revenue	Net income
2025	$5.9bn	$566m
2024	$5.4bn	$456m
2023	$4.8bn	$352m
2022	$4.3bn	$271m
2021	$4.0bn	$412m
2020	$3.6bn	$284m
2019	$4.6bn	$359m
2018	$4.3bn	$292m
2017	$3.9bn	$271m
2016	$3.6bn	$248m
2015	–	$183m
2014	–	$222m
2013	–	$324m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.